Skip to main content
. 2020 Nov 5;12:1758835920970049. doi: 10.1177/1758835920970049

Figure 1.

Figure 1.

Baseline Hb levels associated with (A) progression-free survival and (B) overall survival in patients treated with immune checkpoint inhibitors.

CI, confidence interval; Hb, hemoglobin; HR, hazard ratio; mOS, median overall survival; mPFS, median progression-free survival.